+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Peri-implantitis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 185 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5205000
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Peri-implantitis is reshaping the dental landscape, requiring senior decision-makers to address its clinical complexity and supply chain constraints with integrated strategies. This market report delivers essential, actionable intelligence for suppliers, manufacturers, and procurement leaders responding to evolving clinical, technological, and commercial demands across diverse global care settings.

Market Snapshot: Peri-implantitis Market Dynamics

The Peri-implantitis Market grew from USD 1.22 billion in 2025 to USD 1.30 billion in 2026. It is expected to continue growing at a CAGR of 6.50%, reaching USD 1.90 billion by 2032. Ongoing innovation in adjunctive devices, biomaterials, and laser technologies, combined with shifting regulatory and procurement frameworks, positions this market as a significant segment in dental and surgical care investment portfolios.

Scope & Segmentation

This comprehensive analysis examines the interplay between therapeutic modalities, material advancements, and distribution models shaping peri-implantitis management. Segmentation within the report covers:

  • Product Types: Adjunctive devices, laser treatment, pharmacological treatment, and surgical treatment—each with detailed breakdowns of graft and membrane choices including allograft, autograft, synthetic, xenograft, non-resorbable, and resorbable options.
  • Treatment Modalities: Non-surgical approaches (local antibiotic therapy, mechanical debridement) versus advanced surgical interventions (regenerative and resective procedures supported by sophisticated grafting solutions).
  • End-User Environments: Ambulatory surgery centers, dental clinics, and hospitals, taking into account distinctive procurement cycles and workflow requirements.
  • Distribution Channels: Direct sales, distributors, and online platforms, each influencing purchase access, training, and ongoing support mechanisms.
  • Implant Material Choices: Comparisons between titanium—valued for broad compatibility and clinical familiarity—and zirconia, which is gaining ground in aesthetic and corrosion-sensitive scenarios.
  • Severity Tiers: Pathways differentiated among mild (favoring conservative care), moderate (often combining treatments), and severe cases (requiring complex reconstructive approaches).
  • Regional Coverage: In-depth market and supply analysis for the Americas, EMEA, and Asia-Pacific, emphasizing varied clinical practices, regulatory frameworks, and local supply models.

Key Takeaways for Decision-Makers

  • Integrated clinical and technological approaches are now essential for successful peri-implantitis management, with providers seeking streamlined workflows that link non-surgical, surgical, and adjunctive therapies.
  • Material selection is increasingly tailored, with titanium retaining broad acceptance while zirconia grows in specialized and aesthetic-focused use cases. Suppliers are aligning portfolios to address variable clinical protocols and performance expectations.
  • Purchasing and training models are evolving, with greater emphasis on direct clinician support, bundled procedural solutions, and digital learning to facilitate consistent adoption across provider types.
  • Competitive differentiation revolves around procedural efficiency, evidence-backed clinical outcomes, and the ability to provide bundled device-pharmacologic packages supporting diverse practice environments.
  • Emerging regional dynamics require nuanced go-to-market strategies, with customizable training and supply models supporting both advanced and cost-sensitive markets globally.

Tariff Impact and Supply Chain Adaptation

Anticipated United States tariff adjustments in 2025 present both challenges and opportunities for market participants. Increases in import costs for critical materials like grafts, membranes, and laser platforms could result in elevated landed prices and distributor margin pressure. Suppliers are actively considering domestic or nearshore production, re-engineered logistics, and transparent procurement substitutions to maintain care continuity. Decision-makers should model alternative sourcing scenarios and communicate closely with provider customers to manage inventory and mitigate clinical disruption.

Methodology & Data Sources

This report synthesizes peer-reviewed clinical literature, manufacturer documentation, regulatory filings, and public policy resources to develop a multidimensional view of the peri-implantitis market. Expert validation from clinicians, procurement officials, and industry stakeholders informs key practice, procurement, and distribution insights. Analyses are cross-referenced and triangulated to minimize bias and maximize reliability.

Why This Report Matters

  • Delivers actionable strategic guidance to help manufacturers, distributors, and providers navigate clinical, technological, and commercial shifts.
  • Supports resilient supply chain and procurement decision-making by identifying tariff exposures, alternative sourcing, and continuity-of-care pathways.
  • Enables senior leaders to align product development, marketing, and training programs with evolving clinical and regional needs for sustainable growth.

Conclusion

The future of peri-implantitis care will be shaped by clinical integration, informed material selection, and supply resilience. Organizations that balance technical innovation and practical clinician support will drive improved patient outcomes while securing competitive advantage and commercial growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Peri-implantitis Market, by Product Type
8.1. Adjunctive Devices
8.2. Laser Treatment
8.3. Pharmacological Treatment
8.4. Surgical Treatment
8.4.1. Graft Type
8.4.1.1. Allograft
8.4.1.2. Autograft
8.4.1.3. Synthetic
8.4.1.4. Xenograft
8.4.2. Membrane Type
8.4.2.1. Non-Resorbable
8.4.2.2. Resorbable
9. Peri-implantitis Market, by Treatment Modality
9.1. Non Surgical
9.1.1. Local Antibiotic Therapy
9.1.2. Mechanical Debridement
9.2. Surgical
9.2.1. Regenerative Procedures
9.2.2. Resective Procedures
10. Peri-implantitis Market, by Implant Material
10.1. Titanium
10.2. Zirconia
11. Peri-implantitis Market, by Severity
11.1. Mild
11.2. Moderate
11.3. Severe
12. Peri-implantitis Market, by End User
12.1. Ambulatory Surgery Centers
12.2. Dental Clinics
12.3. Hospitals
13. Peri-implantitis Market, by Distribution Channel
13.1. Direct Sales
13.2. Distributors
13.3. Online Channels
14. Peri-implantitis Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Peri-implantitis Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Peri-implantitis Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Peri-implantitis Market
18. China Peri-implantitis Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. BioHorizons IPH, Inc.
19.6. CAMLOG Biotechnologies GmbH
19.7. DENTSPLY SIRONA Inc.
19.8. Geistlich Pharma AG
19.9. Institut Straumann AG
19.10. MIS Implants Technologies Ltd.
19.11. Nobel Biocare Services AG
19.12. Osstem Implant Co., Ltd.
19.13. Osteogenics Biomedical, Inc.
19.14. Zimmer Biomet Holdings, Inc.
List of Figures
FIGURE 1. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL PERI-IMPLANTITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL PERI-IMPLANTITIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ADJUNCTIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ADJUNCTIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ADJUNCTIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LASER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ALLOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ALLOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AUTOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AUTOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY XENOGRAFT, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY XENOGRAFT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY XENOGRAFT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-RESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-RESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON-RESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESORBABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESORBABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESORBABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LOCAL ANTIBIOTIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LOCAL ANTIBIOTIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY LOCAL ANTIBIOTIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MECHANICAL DEBRIDEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGENERATIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGENERATIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGENERATIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESECTIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESECTIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY RESECTIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TITANIUM, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ZIRCONIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ZIRCONIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ZIRCONIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MILD, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MILD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MILD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MODERATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MODERATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY MODERATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY SEVERE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DENTAL CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 151. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 152. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 154. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 155. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 156. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 157. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 158. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 159. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. EUROPE PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 173. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 176. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 178. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 179. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 180. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 181. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 182. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 183. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. AFRICA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 201. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 203. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 204. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 205. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 206. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 207. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 208. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. ASEAN PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. GCC PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 212. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 213. GCC PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 214. GCC PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 215. GCC PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 216. GCC PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 217. GCC PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 218. GCC PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 219. GCC PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 220. GCC PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. GCC PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 234. BRICS PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 236. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 237. BRICS PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 238. BRICS PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 239. BRICS PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 240. BRICS PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 241. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 242. BRICS PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 243. BRICS PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 244. BRICS PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 245. BRICS PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 246. G7 PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 248. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 249. G7 PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 250. G7 PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 251. G7 PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 252. G7 PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 253. G7 PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 254. G7 PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 255. G7 PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 256. G7 PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 257. G7 PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 258. NATO PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 260. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 261. NATO PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 262. NATO PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 263. NATO PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 264. NATO PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 265. NATO PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 266. NATO PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 267. NATO PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 268. NATO PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 269. NATO PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL PERI-IMPLANTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 283. CHINA PERI-IMPLANTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA PERI-IMPLANTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 285. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL TREATMENT, 2018-2032 (USD MILLION)
TABLE 286. CHINA PERI-IMPLANTITIS MARKET SIZE, BY GRAFT TYPE, 2018-2032 (USD MILLION)
TABLE 287. CHINA PERI-IMPLANTITIS MARKET SIZE, BY MEMBRANE TYPE, 2018-2032 (USD MILLION)
TABLE 288. CHINA PERI-IMPLANTITIS MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
TABLE 289. CHINA PERI-IMPLANTITIS MARKET SIZE, BY NON SURGICAL, 2018-2032 (USD MILLION)
TABLE 290. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SURGICAL, 2018-2032 (USD MILLION)
TABLE 291. CHINA PERI-IMPLANTITIS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2032 (USD MILLION)
TABLE 292. CHINA PERI-IMPLANTITIS MARKET SIZE, BY SEVERITY, 2018-2032 (USD MILLION)
TABLE 293. CHINA PERI-IMPLANTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 294. CHINA PERI-IMPLANTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Peri-implantitis market report include:
  • BioHorizons IPH, Inc.
  • CAMLOG Biotechnologies GmbH
  • DENTSPLY SIRONA Inc.
  • Geistlich Pharma AG
  • Institut Straumann AG
  • MIS Implants Technologies Ltd.
  • Nobel Biocare Services AG
  • Osstem Implant Co., Ltd.
  • Osteogenics Biomedical, Inc.
  • Zimmer Biomet Holdings, Inc.

Table Information